Skip to main content

and
  1. No Access

    Article

    CD226: a potent driver of antitumor immunity that needs to be maintained

    Jiacheng Bi in Cellular & Molecular Immunology (2022)

  2. Article

    NK cell dysfunction in patients with COVID-19

    Jiacheng Bi in Cellular & Molecular Immunology (2022)

  3. No Access

    Article

    The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy

    Cytokines exert powerful immunomodulatory effects that are critical to physiology and pathology in humans. The application of natural cytokines in clinical studies has not been clearly established, and there a...

    **aohu Zheng, Yaqi Wu, Jiacheng Bi, Yingying Huang in Cellular & Molecular Immunology (2022)

  4. No Access

    Article

    Increased expression of adenosine A3 receptor in tumor-infiltrating natural killer cells

    Jiacheng Bi, Chaoyue Zheng, **aohu Zheng in Cellular & Molecular Immunology (2021)

  5. No Access

    Article

    IL-33-induced reactive oxygen species are required for optimal metabolic programming in group 2 innate lymphoid cells

    Chaoyue Zheng, Haisi Wu, Zhen Lu, Jiacheng Bi in Cellular & Molecular Immunology (2020)

  6. No Access

    Article

    Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity

    Checkpoint blockade enhances effector T cell function and has elicited long-term remission in a subset of patients with a broad spectrum of cancers. TIGIT is a checkpoint receptor thought to be involved in med...

    Qing Zhang, Jiacheng Bi, **aodong Zheng, Yongyan Chen, Hua Wang in Nature Immunology (2018)